Evidence map›Paper›PMID 25375138›Full record

ArticlePloS one2014

Sensitivity and specificity of point-of-care rapid combination syphilis-HIV-HCV tests.

Kristen L Hess, Dennis G Fisher, Grace L Reynolds

Abstract readEvaluation Study
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Laboratory Evaluation of the Chembio DPP Syphilis Screen & Confirm Point-of-Care Test on Serum and Simulated Blood Samples.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2024
    Article
  8. Point-of-Care Diagnostics for Diagnosis of Active Syphilis Infection: Needs, Challenges and the Way Forward.International journal of environmental research and public health · 2022
    Article
  9. Article
  10. Canadian Public Health Laboratory Network guidelines for the use of point-of-care tests forJournal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. An evaluation of the SD Bioline HIV/syphilis duo test.International journal of STD & AIDS · 2018
    Article
  17. Article
  18. Article
  19. Syphilis: Re-emergence of an old foe.Microbial cell (Graz, Austria) · 2016
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kristen L HessCenter for Behavioral Research and Services, California State University Long Beach, Long Beach, California, United States of America.
Dennis G FisherCenter for Behavioral Research and Services, California State University Long Beach, Long Beach, California, United States of America.
Grace L ReynoldsCenter for Behavioral Research and Services, California State University Long Beach, Long Beach, California, United States of America.

Funding

RIMI-CSULBP20MD003942 · NIMHD · CALIFORNIA STATE UNIVERSITY LONG BEACH · PI CONOLEY, JANE CLOSE · 2009 to 2013
$4.6M
Supplement to Behavioral Science AspectsR01DA030234 · NIDA · CALIFORNIA STATE UNIVERSITY LONG BEACH · PI FISHER, DENNIS G · 2010 to 2013
$1.8M
NIDA NIH HHS R01 DA030234NIDA NIH HHS R01DA030234NIMHD NIH HHS P20 MD003942NIMHD NIH HHS P20MD003942
6 · The paper itself

Abstract

backgroundNew rapid point-of-care (POC) tests are being developed that would offer the opportunity to increase screening and treatment of several infections, including syphilis. This study evaluated three of these new rapid POC tests at a site in Southern California.

methodsParticipants were recruited from a testing center in Long Beach, California. A whole blood specimen was used to evaluate the performance of the Dual Path Platform (DPP) Syphilis Screen & Confirm, DPP HIV-Syphilis, and DPP HIV-HCV-Syphilis rapid tests. The gold-standard comparisons were Treponema pallidum passive particle agglutination (TPPA), rapid plasma reagin (RPR), HCV enzyme immunoassay (EIA), and HIV-1/2 EIA.

resultsA total of 948 whole blood specimens were analyzed in this study. The sensitivity of the HIV tests ranged from 95.7-100% and the specificity was 99.7-100%. The sensitivity and specificity of the HCV test were 91.8% and 99.3%, respectively. The treponemal-test sensitivity when compared to TPPA ranged from 44.0-52.7% and specificity was 98.7-99.6%. The non-treponemal test sensitivity and specificity when compared to RPR was 47.8% and 98.9%, respectively. The sensitivity of the Screen & Confirm test improved to 90.0% when cases who were both treponemal and nontreponemal positive were compared to TPPA+/RPR ≥ 1 ∶ 8.

conclusionsThe HIV and HCV on the multi-infection tests showed good performance, but the treponemal and nontreponemal tests had low sensitivity. These results could be due to a low prevalence of active syphilis in the sample population because the sensitivity improved when the gold standard was limited to those more likely to be active cases. Further evaluation of the new syphilis POC tests is required before implementation into testing programs.

Indexed as

Point-of-Care SystemsFemaleHepatitis CHIV InfectionsHumansImmunoenzyme TechniquesMaleSensitivity and SpecificitySyphilisSyphilis SerodiagnosisTreponema pallidum

Identifiers

PMID25375138
PMCPMC4223032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.